The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome

被引：8
|
作者：
Wang, Bei [1 ]
Xu, Wen [1 ]
Cai, Yuxuan [1 ]
Liu, Kai [1 ]
Wu, Jiacheng [1 ]
Guo, Chong [1 ]
Yuan, Chengfu [1 ,2 ,3 ]
机构：
[1] China Three Gorges Univ, Coll Med Sci, Yichang 443002, Peoples R China
[2] China Three Gorges Univ, Grade Pharmacol Lab Chinese Med 3, State Adm Tradit Chinese Med, Yichang 443002, Peoples R China
[3] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotherapy, Yichang 443002, Peoples R China
来源：
CURRENT PHARMACEUTICAL DESIGN | 2021年 / 27卷 / 39期
关键词：
Long non-coding RNA; BCAR4; cancer; biomarkers; prognosis; NONCODING RNA BCAR4; SOLID-PHASE SYNTHESIS; GASTRIC-CANCER; PROMOTES PROLIFERATION; TAMOXIFEN RESISTANCE; CELL-PROLIFERATION; AGGRESSIVENESS; PROGRESSION; EXPRESSION; APOPTOSIS;
D O I：
10.2174/1381612827666210604114955
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Long non-coding RNA (lncRNA) breast cancer anti-estrogen resistance 4 (BCAR4) is a characterized oncogenic lncRNA in different cancers. This review is dedicated to summarize various molecular mechanisms of BCAR4 and demonstrate that the biological functions exerted by BCAR4 are good entry points for therapy. Methods: The molecular mechanism of BCAR4 acting on tumors is summarized by reviewing PubMed. Results: The expression of lncRNA BCAR4 is abnormally increased in all kinds of tumors, including colorectal cancer, prostate cancer, bladder cancer, gastric cancer, chondrosarcoma, glioma, breast cancer, glioma, gastric cancer, liver cancer, cervical cancer, lung cancer,etc. Besides, BCAR4 mediates multiple processes involved in carcinogenesis, including proliferation, invasion, anti-apoptosis, migration. Conclusion: BCAR4 may show great clinical value in this direction as a therapeutic cancer target.
引用
收藏
页码：4107 / 4113
页数：7
相关论文
共 50 条
  • [21] The role of long non-coding RNA BCAR4 in human cancers
    Yi, Qiong
    Liu, Zhongcheng
    Zhang, Kun
    Liu, Xuening
    Wang, Lifu
    Geng, Bin
    Xia, Yayi
    [J]. HUMAN CELL, 2021, 34 (05) : 1301 - 1309
  • [22] LncRNA BCAR4 promotes liver cancer progression by upregulating ANAPC11 expression through sponging miR-1261
    Zhang, Yu
    Zhou, Hongyan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (01) : 159 - 166
  • [23] The effect of targeted regulation of LATS2 by LncRNA BCAR4 on proliferation, migration and apoptosis of HCC cells
    Huang, Yuntao
    Rao, Xiaohui
    Luo, Yunfan
    Deng, Yu
    Zhong, Chunqiang
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 4624 - 4631
  • [24] Identification of signaling pathways activated by BCAR4 expression in human breast cancer
    Godinho, Marcia F. E.
    Wulfkuhle, Julia D.
    Petricoin, Emanuel F.
    Dorssers, Lambert C. J.
    van Agthoven, Ton
    [J]. CANCER RESEARCH, 2011, 71
  • [25] Investigating the role of BCAR4 in ovarian physiology and female fertility by genome editing in rabbit
    Maud Peyny
    Peggy Jarrier-Gaillard
    Laurent Boulanger
    Nathalie Daniel
    Sébastien Lavillatte
    Véronique Cadoret
    Pascal Papillier
    Danielle Monniaux
    Nathalie Peynot
    Véronique Duranthon
    Geneviève Jolivet
    Rozenn Dalbies-Tran
    [J]. Scientific Reports, 10
  • [26] Breast cancer anti-estrogen resistance 4 (BCAR4) is a novel oncogene in lung cancer
    Bae, Kieun
    Lee, Minkyong
    Yoon, Daseul
    Kim, Yun-Hee
    Yoon, Kyong-Ah
    [J]. CANCER RESEARCH, 2017, 77
  • [27] Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
    Tangwei Wu
    Xiaoyi Li
    Ge Yan
    Zheqiong Tan
    Dan Zhao
    Shuiyi Liu
    Hui Wang
    Yuan Xiang
    Weiqun Chen
    Hongda Lu
    Xinghua Liao
    Yong Li
    Zhongxin Lu
    [J]. Journal of Experimental & Clinical Cancer Research, 42
  • [28] RETRACTED ARTICLE: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
    Tangwei Wu
    Xiaoyi Li
    Ge Yan
    Zheqiong Tan
    Dan Zhao
    Shuiyi Liu
    Hui Wang
    Yuan Xiang
    Weiqun Chen
    Hongda Lu
    Xinghua Liao
    Yong Li
    Zhongxin Lu
    [J]. Journal of Experimental & Clinical Cancer Research, 42
  • [29] Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
    Bae, Kieun
    Kim, Jin Hee
    Lee, Ja Young
    Kong, Sun-Young
    Kim, Yun-Hee
    Kim, Sunshin
    Yoon, Kyong-Ah
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [30] Investigating the role of BCAR4 in ovarian physiology and female fertility by genome editing in rabbit
    Peyny, Maud
    Jarrier-Gaillard, Peggy
    Boulanger, Laurent
    Daniel, Nathalie
    Lavillatte, Sebastien
    Cadoret, Veronique
    Papillier, Pascal
    Monniaux, Danielle
    Peynot, Nathalie
    Duranthon, Veronique
    Jolivet, Genevieve
    Dalbies-Tran, Rozenn
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
12345